Oncopeptides AB (publ) (STO:ONCO)

Sweden · Delayed Price · Currency is SEK

1.635

-0.185 (-10.16%)

May 22, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	35.22M	8.36M	118.30M
Biotechnology Growth	321.54%	-92.94%	-
Total	35.22M	8.36M	118.30M
Total Growth	321.54%	-92.94%	-

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe	-	560.00K	-
USA	24.33M	7.80M	118.30M
USA Growth	212.12%	-93.41%	-
Germany	6.57M	-	-
Greece	4.32M	-	-
Total	35.22M	8.36M	118.30M
Total Growth	321.54%	-92.94%	-

Source: S&P Global Market Intelligence.